129 related articles for article (PubMed ID: 463697)
21. Bioanalysis and disposition of alpha-fluoromethylhistidine, a new histidine decarboxylase inhibitor.
August TF; Musson DG; Hwang SS; Duggan DE; Hooke KF; Roman IJ; Ferguson RJ; Bayne WF
J Pharm Sci; 1985 Aug; 74(8):871-5. PubMed ID: 4032273
[TBL] [Abstract][Full Text] [Related]
22. Pyridoxal 5'-phosphate-dependent histidine decarboxylase. Mechanism of inactivation by alpha-fluoromethylhistidine.
Bhattacharjee MK; Snell EE
J Biol Chem; 1990 Apr; 265(12):6664-8. PubMed ID: 2182624
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat.
Westerberg VS; Geiger JD
Pharmacol Biochem Behav; 1987 Nov; 28(3):419-22. PubMed ID: 3685079
[TBL] [Abstract][Full Text] [Related]
24. The effect of two inhibitors of histidine decarboxylase on gastric secretion in the rat.
Megazzini P; Bacciarelli C
Arzneimittelforschung; 1977; 27(3):620-3. PubMed ID: 577431
[TBL] [Abstract][Full Text] [Related]
25. Effects of alpha-fluoromethylhistidine on increase in histidine decarboxylase activity of maternal mouse kidney observed during late pregnancy and evidence for its non-mast cell origin by using estrogen and W/WV mice.
Maeyama K; Ohno A; Taguchi Y; Watanabe T; Wada H
Jpn J Pharmacol; 1985 Oct; 39(2):145-51. PubMed ID: 3841376
[TBL] [Abstract][Full Text] [Related]
26. Properties of rat brain histidine decarboxylase.
Palacios JM; Mengod G; Picatoste F; Grau M; Blanco I
J Neurochem; 1976 Dec; 27(6):1455-60. PubMed ID: 12251
[No Abstract] [Full Text] [Related]
27. Treatment of two mastocytosis patients with a histidine decarboxylase inhibitor.
Granerus G; Olafsson JH; Roupe G
Agents Actions; 1985 Apr; 16(3-4):244-8. PubMed ID: 4013913
[TBL] [Abstract][Full Text] [Related]
28. Mammalian histidine decarboxylase and its suicide substrate alpha-fluoromethylhistidine.
Wada H; Watanabe T; Maeyama K; Taguchi Y; Hayashi H
Prog Clin Biol Res; 1984; 144A():245-54. PubMed ID: 6374673
[No Abstract] [Full Text] [Related]
29. Enhancement by alpha-fluoromethylhistidine of the thiopental sleep-prolonging action of delta 9-tetrahydrocannabinol.
Oishi R; Itoh Y; Nishibori M; Saeki K; Ueki S
Psychopharmacology (Berl); 1988; 95(1):77-81. PubMed ID: 2838862
[TBL] [Abstract][Full Text] [Related]
30. Increase in histidine decarboxylase activity in mouse skin after application of the tumor promoter tetradecanoylphorbol acetate.
Watanabe T; Taguchi Y; Sasaki K; Tsuyama K; Kitamura Y
Biochem Biophys Res Commun; 1981 May; 100(1):427-32. PubMed ID: 7259759
[No Abstract] [Full Text] [Related]
31. Role of histidine-decarboxylase inhibitors on gastric acid secretion in the rat.
Castellucci A; Megazzini P
Arzneimittelforschung; 1976; 26(1):62-5. PubMed ID: 947180
[TBL] [Abstract][Full Text] [Related]
32. A coupled assay for histidine decarboxylase: in vivo turnover of this enzyme in mouse brain.
Keeling DJ; Smith IR; Tipton KF
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):215-21. PubMed ID: 6472496
[TBL] [Abstract][Full Text] [Related]
33. Specificity in enzyme inhibition. 3. Synthesis of 5-substituted 2,2-dimethyl-4-imidazolidinones as inhibitors of tyrosine decarboxylase and histidine decarboxylase.
Smissman EE; Inloes RL; El-Antably S; Shaffer PJ
J Med Chem; 1976 Jan; 19(1):161-3. PubMed ID: 173851
[TBL] [Abstract][Full Text] [Related]
34. In vitro inhibition of rat hypothalamus histidine decarboxylase by a specific inhibitor--4-imidazolyl-3-amino-2-butanone (McN-A-1293).
Bielkiewicz B; Maslinski C
Biochem Pharmacol; 1978; 27(24):2977-8. PubMed ID: 736993
[No Abstract] [Full Text] [Related]
35. The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction.
Pipkorn U; Granerus G; Proud D; Kagey-Sobotka A; Norman PS; Lichtenstein LM; Naclerio RM
Allergy; 1987 Oct; 42(7):496-501. PubMed ID: 3318539
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of histamine synthesis in vitro and in vivo by S-alpha-fluoromethylhistidine.
Duggan DE; Hooke KF; Maycock AL
Biochem Pharmacol; 1984 Dec; 33(24):4003-9. PubMed ID: 6439218
[TBL] [Abstract][Full Text] [Related]
37. Induced histidine decarboxylase in endotoxic shock: identification of the enzyme in rat liver and influence of its inhibitors on survival parameters.
Neugebauer E; Beckurts T; Lorenz W; Maroske D; Merte H; Horeyseck G; Dietz W
Agents Actions; 1986 Apr; 18(1-2):23-9. PubMed ID: 3728207
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of gastric acid secretion by 4-imidazolyl-3-amino-2-butanone (McN-A-1293), a specific inhibitor of histidine decarboxylase.
Taylor RJ
Biochem Pharmacol; 1978; 27(22):2653-4. PubMed ID: 728219
[No Abstract] [Full Text] [Related]
39. Inhibition of histidine decarboxylase by imidazole derivatives.
Kelley JL; McLean EW; Miller CA
J Pharm Sci; 1981 Mar; 70(3):341-3. PubMed ID: 7264907
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of five N-derivatives of 1,2,3,4-tetrahydroisoquinoline and three N alpha terminal histidine peptides as potential gastric histidine decarboxylase inhibitors.
Agostini O; Bacciarelli C; Bonacchi G; Boni P; Castellucci A; Fedi M
Boll Chim Farm; 1983 Feb; 122(2):86-95. PubMed ID: 6871041
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
